ArticleJTO clinical and research reports2022

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.

Apar Pataer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.